NATIONAL REGISTRIES OF RARE DISEASES IN EUROPE: AN OVERVIEW BY THE EPIRARE PROJECT.

Similar documents
Fit4RareFit4All Conference Cluj - Napoca 3-4 September 2017

III. KNOWLEDGE BASE ON THE 65 CAUSES OF DEATH (EUROSTAT SHORT LIST)

The EU rare diseases policy framework: the context for ERNs

Overview of European Consumption Databases

rare diseases research through National Plans and Strategies

The French National Rare Diseases Registries BNDMR-BaMaRa and RaDiCo

ICD-10 Back Up The Truck. Andrea Romero, RHIT, CCS, CPC NMHIMA Leadership Conference April 10, 2014

SUMMARY COMPARISON OF NATIONAL PLANS AND PRACTICES. Domenica Taruscio

EPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS

Towards Integrated Syndromic Surveillance in Europe?

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Smokefree Policies in Europe: Are we there yet?

COMMISSION OF THE EUROPEAN COMMUNITIES

(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies)

ICD-10-CM Foundation Training

Extract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study

EUROPLAN National Conferences and Post-NCs activities in support to Member States

ECOO European Diploma in Optometry and Optics ECOO European Diploma in Optics A Status Report

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

Joint Programming in Neurodegenerative Disease Research (JPND)

Approved. PASS INFORMATION Title

Recalling Resolution (59) 23 of 16 November 1959, on the extension of the activities of the Council of Europe in the social and cultural fields;

Workshop on Accident Analysis and Risk Assessment A JRC Enlargement Workshop

Meeting with EMA: cooperation in the field of ERNs. Enrique Terol DG SANTE European Commission

A chapter by chapter look at the ICD-10-CM code set Coding Tip Sheet

Linkage of birth data in Europe. Marie Delnord EPOPé INSERM

NORDIC CONFERENCE ON RARE DISEASES

HI-1051: Certified Professional Coder Preparation Course

Challenges in Palliative Care Education

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Type 1 Diabetes Australian Research Impact Analysis

the patients perspective and role of epags

Quality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view.


Overview of drug-induced deaths in Europe - What does the data tell us?

System and Role of Pharmacovigilance in Implementing the Ukraine National TB Control Program

ecall deployment in Europe - Lessons learnt from the HeERO project Gary Machado, EENA Jerome Paris, EENA

Useful EU information on organ donation and transplantation

EPIDEMIOLOGY. Accurate, in-depth information for understanding and assessing targeted markets

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

AHIMA Academy for ICD-10-CM/PCS: Building Expert Trainers in Diagnosis and Procedure Coding

Alcohol Prevention Day

The health economic landscape of cancer in Europe

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Table Of Content. European Rare Kidney Diseases Reference Network... 2 Summary... 3 Work Package... 9

Cross Border Genetic Testing for Rare Diseases

Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA

Extrapolation and potential impact of IPHS deployment in Europe

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

What s s on the Menu in Europe? - overview and challenges in the first pan- European food consumption survey

STRATEGIC APPROACH & WORKPLAN 2007

European Status report on Alcohol and Health

Clinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin

the EUROPEAN COMMISSION INITIATIVE

How to measure impact of rotavirus vaccination: Opportunities for synergies across Nordic countries?

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Giardiasis (lambliasis)

Weimin YE Professor Department of Medical Epidemiology and Biostatistics Karolinska Institutet

Use of international databases national perspective. Mika Gissler National Institute for Health and Welfare, Finland Karolinska Institutet, Sweden

Course Outline Introduction to ICD-10 Coding Course

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

Where we stand in EFORT

GLP in the European Union Ecolabel detergents, GLP and accreditation

Homeopathy and Anthroposophic Medicine THEIR PLACE IN EUROPEAN HEALTH CARE

The Identification of Food Safety Priorities using the Delphi Technique

Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA

Better access to medicines Sydney Ian Banks President European Men s Health Forum (with thanks to Alan White)

PHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe

Spain. Belgium. France. Portugal. Austria. Ireland. Italy. Finland. Netherlands. Germany. Canada. Sweden. Denmark. Switzerland. Australia.

Child mortality of children aged 5-15 years in the UK and Sweden: a comparison

European Partnership for Screening

ORGANIZERS. National Association GENETIKA (Russia)

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

WCPT COUNTRY PROFILE December 2017 SWEDEN

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

Hospital admissions in migrant and native groups in the Netherlands

Table Of Content. European Surveillance of Congenital Anomalies (Phase 3)... 3 Summary... 4 Coordinator, Leader contact and partners...

Media monitoring: Experience of outbreak monitoring at ECDC to monitor vaccine safety potential crisis- A pilot using MediSYS

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Screening for Cervical Cancer in Europe

State of provision of Hearing Aids in Europe

Fertility preservation regulations for oocytes, embryos and ovarian tissue: storage (and use)

Isle of Wight Joint Strategic Needs Assessment: Core Dataset 2009

Optum360 Learning: Detailed Instruction for Appropriate ICD-10-CM Coding

Information resources for healthcare professionals on immunisation schedules and vaccines in EU countries

WCPT COUNTRY PROFILE December 2017 HUNGARY

EUVAC.NET A surveillance network for vaccine-preventable diseases

WCPT COUNTRY PROFILE December 2017 SERBIA

Meeting report, September 2005

The European Commission s science and knowledge service. Joint Research Centre

ICD-9-CMCoding I Common Course Outline

Transcription:

D. Taruscio and L. Vittozzi National Centre for Rare Diseases National Institute of Health Rome, Italy NATIONAL REGISTRIES OF RARE DISEASES IN EUROPE: AN OVERVIEW BY THE EPIRARE PROJECT. ICORD 2014, Ede (NL), 7-9 October, 2014

The RD Registries in EU More than 600 rare disease registries (Orphanet and other sources) No uniform standards for the storing and management of data Registries set up for a small fraction of rare diseases, multiple registries for the same disease Need to increase data comparability and sharing Need to harmonise existing regulations (EU, national and regional)

The EU initiatives COUNCIL RECOMMENDATION on an action in the field of rare diseases (2009): Recommends that Member States support at all appropriate levels, for epidemiological purposes, registries and databases Funding priorities include RD registries and disease networks EPIRARE EU Platform for RD registries (Building Consensus and Synergies for EU Registration of RD patients) RD-Connect PARENT ERNs Other disease-specific projects EU Platform for the Registration of RD patients (JRC, Ispra)

The European RDR Platform objectives To Increase sustainability To improve data comparability, by means : Reference set of Common Data Elements Reference coding and catalogues Reference data quality assurance procedures Provision of useful tools

The opportunity offered by National (institutional) registries Improved epidemiological information on RD, by means of: Integration of multiple national sources Mortality/Population Registry E-prescription Electronic Health Records Increased completeness of case ascertainment E.g.: designation of CoE linked to case notification and follow-up E.g.: Mandatory registration of patients E.g.: Registration linked to prescriptions Appropriate management of data protection rules E.g.: Legal basis of data collection E.g.: Appropriate procedures for data protection

National (institutional) RD Registries Running: Italy (2001) France (2005; 2007) Spain (2008) Belgium (2013) Nordic Countries (Denmark, Finland, Norway and Sweden): craniofacial diseases, being expanded to all very rare diseases Finland (a general disease registry, including RD) Under planning: Bulgaria Germany (very rare and undiagnosed diseases) Sweden

www.epirare.eu

National Registries (NR) operation Country Belgium, France, Italy Spain Legal basis The NR activity is part of the mandatory activities of the healthcare network of centres dedicated to RD. The NR is funded as a research project, with the Involvement of institutional, scientific, patient, and industry stakeholders. Country Belgium,Italy, Spain France Patient coding Univocal, but not common, patient coding system De-identification

National Registries (NR) operation Country Scope Aims Belgium France Italy Spain All diagnosed RD surveillance, public health planning +... +patient recruitment, clinical research +patient recruitment, source integration (EHR) +clinical research (not supported yet) +patient recruitment, translational research, social policies

National Registries (NR) operation Country Belgium France Italy Spain Common Data Elements (central repository) Patient ID code and demographic data, death date, registering centre and treating physicians codes; first symptom onset date, diagnosis and its features, and different options of patient consent. Patient ID code and demographic data, patient consent, familiarity of the disease, death date and cause, drug treatment, services data, diagnosis and its features, fetus and newborn data, data on research participation and biological sample donations. patient ID code and demographic data, live or dead status and death date, diagnosis, diagnosis date, diagnosis centre data, first symptom onset date, prescribed orphan drug, cost exemption code Temporarily: patient ID code, demographic data, diagnosis.

National Registries: hurdles or opportunities? National Registries are developing independently from each other. Different CDEs Different patient univocal coding systems Partially overlapping aims Possibly different indicators

The Italian Network for the Registration of RD patients NATIONAL REGISTRY FOR RARE DISEASES Minimum Data Set Regional Registry of RD - Interregional Reference Centre Trusted Centres in a given region

Rare Diseases in NRRD (2013) grouped by ICD-9 Chapters (N = 110841 records) records % Diseases of the Central Nervous System and Sense Organs 28784 26 Congenital Anomalies 21836 19,7 Endocrine, Nutritional, Metabolic Diseases, and Immunity Disorders 19279 17,4 Diseases of the Blood and Blood-Forming Organs 18452 16,6 Diseases of the Musculoskeletal System and Connective Tissue 6124 5,5 Neoplasms 5596 5 Diseases of the Circulatory System 4738 4,3 Diseases of the Skin and Subcutaneous Tissue 3666 3,3 Diseases of the Digestive System 1484 1,3 Diseases of the Genitourinary System 627 0,6 Infectious and Parasitic Diseases 144 0,1 Certain Conditions Originating in the Perinatal Period 108 0,1 Symptoms, Signs, and Ill-Defined Conditions 3 0

Thank you for your attention! DomenicaTaruscio domenica.taruscio@iss.it

The Spanish RDR From Manuel Posada, presented at the EPIRARE Workshop on National Rare Diseases Registries. Rome, 5 March 2014

The Spanish RDR From Manuel Posada, presented at the EPIRARE Workshop on National Rare Diseases Registries. Rome, 5 March 2014

The Spanish RDR From Manuel Posada, presented at the EPIRARE Workshop on National Rare Diseases Registries. Rome, 5 March 2014

The French network From Paul Landais, presented at the EPIRARE Workshop on National Rare Diseases Registries. Rome, 5 March 2014

The French network From Paul Landais, presented at the EPIRARE Workshop on National Rare Diseases Registries. Rome, 5 March 2014

The Ra.Di.Co. section From Paul Landais, presented at the EPIRARE Workshop on National Rare Diseases Registries. Rome, 5 March 2014

The Ba.Ma.Ra. section From Paul Landais, presented at the EPIRARE Workshop on National Rare Diseases Registries. Rome, 5 March 2014